The global virus filtration market is valued at approximately USD 5.22 billion in 2024 and is expected to grow to USD 5.75 billion by 2025. By 2034, the market is projected to reach around USD 13.7 billion, reflecting a robust compound annual growth rate (CAGR) of 10.5% from 2024 to 2034. This growth is fueled by the rapidly evolving biotechnology sector, increased production of biotech products, and continuous technological advancements in filtration techniques.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5360
Virus Filtration Market: Ensuring Safety in Biologics Production
Virus filtration is a critical technology for ensuring virus clearance, widely used in the production of biological therapeutics. Products manufactured using mammalian cell lines or human plasma are vulnerable to contamination by both known and unknown viruses. To address this risk, regulatory authorities require the integration of virus filtration in the manufacturing process. These filters, designed to separate viruses based on size, play a pivotal role in safeguarding biologics from contamination during downstream processing.
As the global biotechnology sector grows, fueled by increasing investments and strategic collaborations, the demand for virus filtration technologies is rising. The expanding production of biologics as therapeutic solutions further propels this market. Additionally, stringent regulatory requirements for virus removal during manufacturing drive the adoption of virus filtration systems, underscoring their importance in maintaining safety and quality standards.
Leading Players in the Virus Filtration Market
The virus filtration market is dominated by several key companies, each contributing significantly to innovation and growth in the sector:
- 3M: Renowned for its advanced filtration technologies, 3M provides solutions that enhance viral safety in biologics manufacturing.
- Asahi Kasei Medical Co. Ltd.: A global leader in virus removal filters, offering products tailored for efficient downstream processing in biologics.
- Charles River Laboratories International, Inc.: Specializes in comprehensive biopharmaceutical testing services, including virus filtration validation.
- Clean Cell, Inc.: Provides virus clearance testing and filtration solutions to ensure safety in pharmaceutical processes.
- Cytiva Lifesciences: A Danaher company known for its robust filtration systems designed for biomanufacturing applications.
- Danaher Corporation: Drives innovation through its subsidiaries like Cytiva, delivering advanced filtration technologies.
- Merck KGaA: Offers high-performance virus filtration systems as part of its life science solutions portfolio.
- Parexel: Focuses on biopharmaceutical services, including virus clearance strategies to meet regulatory requirements.
- Qiagen: Provides sample preparation and purification technologies, enhancing viral safety in biotech workflows.
- Sartorius AG: A leading provider of filtration equipment, Sartorius supports scalable solutions for biologics production.
- Sigma Aldrich: Part of Merck, offering a wide range of products for virus filtration in research and manufacturing.
- TeraPore Technologies: Innovates in high-selectivity filtration materials for efficient virus removal.
- Wuxi Biologics: Provides integrated services, including virus filtration, to streamline biologics development and manufacturing.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/virus-filtration-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5360
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare